FAM238B: A Potential Drug Target Or Biomarker (G731789)

Target Name: FAM238B

NCBI ID: G731789

FAM238B

Other Name(s): family with sequence similarity 238 member B | LINC00202-2 | Family with sequence similarity 238 member B

FAM238B: A Potential Drug Target Or Biomarker

The FAM238B protein is a member of the family with sequence similarity (FAM) family, which is a group of proteins that share a conserved domain that is involved in various cellular processes. One of the interesting aspects of the FAM238B protein is its potential as a drug target or biomarker.

The FAM238B protein is a 21-kDa protein that is expressed in various tissues of the body, including the brain, heart, and gastrointestinal tract. It is characterized by a N-terminal alpha-helix, a middle alpha-helix, and a C -terminal T-loop, which is composed of a series of parallel beta-strands. The protein also has a variable andoleucine rich region (VOR) at its C-terminus, which is known to be involved in protein-protein interactions and may play a role in the protein's stability and functions.

The FAM238B protein is involved in various cellular processes, including cell signaling, cell adhesion, and cell survival. It has been shown to be involved in several signaling pathways, including the TGF-beta pathway, the Wnt pathway, and theNotch pathway. In addition , the FAM238B protein has also been shown to play a role in cell adhesion and migration, as well as in the regulation of cell survival and apoptosis.

Furthermore, the FAM238B protein has been shown to be a potential drug target or biomarker in several diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. For example, several studies have shown that the FAM238B protein is overexpressed in various types of cancer, including breast, ovarian, and colorectal cancer. In addition, the protein has also been shown to be involved in the development and progression of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease.

Another study has shown that the FAM238B protein is involved in the regulation of cell apoptosis, which is the process by which cells die and are removed from the body. This suggests that the protein may play a role in the development and progression of certain types of neurodegenerative diseases, such as Alzheimer's disease.

In addition, the FAM238B protein has also been shown to be involved in the regulation of cell signaling pathways. For example, the protein has been shown to play a role in the regulation of the androgen signaling pathway, which is involved in the regulation of male sexual function and the development of male characteristics.

Finally, the FAM238B protein has also been shown to be involved in the regulation of cell volume and cytoskeletal organization. This suggests that the protein may play a role in the regulation of cell size and shape, as well as in the organization of the cytoskeleton.

In conclusion, the FAM238B protein is a member of the family with sequence similarity family that is involved in various cellular processes in the body. Its potential as a drug target or biomarker makes it an attractive target for future research in the field of pharmaceuticals. Further studies are needed to fully understand the role of the FAM238B protein in cellular processes and its potential as a drug target or biomarker.

Protein Name: Family With Sequence Similarity 238 Member B

The "FAM238B Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FAM238B comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets